Biotechnology

Amgen Discloses Unauthorized Cloud Data Exfiltration and Patient PHI Theft in SEC Form 8-K Filing

Biotechnology giant Amgen files SEC Form 8-K Item 1.05 after unauthorized actors infiltrated third-party cloud environments and exfiltrated sensitive patient PHI and clinical research data.